|
gptkb:advanced_hormone_receptor-positive,_HER2-negative_breast_cancer
|
gptkb:palbociclib
|
|
gptkb:EGFR_mutation-positive_non-small_cell_lung_cancer
|
gptkb:erlotinib
|
|
gptkb:HER2-mutant_non-small_cell_lung_cancer
|
HER2 inhibitor
|
|
gptkb:Philadelphia_chromosome-positive_acute_lymphoblastic_leukemia
|
tyrosine kinase inhibitors
|
|
gptkb:BRAF_V600E-positive_melanoma
|
gptkb:MEK_inhibitors
|
|
gptkb:EGFR_mutation-positive_non-small_cell_lung_cancer
|
gptkb:osimertinib
|
|
gptkb:RET_fusion-positive_thyroid_cancer
|
gptkb:selpercatinib
|
|
gptkb:advanced_hormone_receptor-positive,_HER2-negative_breast_cancer
|
gptkb:fulvestrant
|
|
gptkb:advanced_hormone_receptor-positive,_HER2-negative_breast_cancer
|
gptkb:ribociclib
|
|
gptkb:non-small_cell_lung_carcinoma
|
immune checkpoint inhibitors
|
|
gptkb:RET_fusion-positive_thyroid_cancer
|
gptkb:pralsetinib
|
|
gptkb:non-small_cell_lung_carcinoma
|
tyrosine kinase inhibitors
|
|
gptkb:EGFR_mutation-positive_non-small_cell_lung_cancer
|
gptkb:afatinib
|
|
gptkb:advanced_hormone_receptor-positive,_HER2-negative_breast_cancer
|
gptkb:alpelisib
|
|
gptkb:EGFR_mutation-positive_NSCLC
|
gptkb:EGFR_tyrosine_kinase_inhibitor
|
|
gptkb:BRAF_V600E-positive_melanoma
|
gptkb:BRAF_inhibitors
|
|
gptkb:advanced_hormone_receptor-positive,_HER2-negative_breast_cancer
|
gptkb:abemaciclib
|
|
gptkb:EGFR_mutation-positive_non-small_cell_lung_cancer
|
gptkb:gefitinib
|
|
gptkb:EGFR_mutation-positive_non-small_cell_lung_cancer
|
gptkb:dacomitinib
|